A House Ways and Means Subcommittee on Oversight hearing recently reviewed the effects of the Affordable Care Act (ACA) on health insurance premiums. In addition, a House Energy and Commerce Health Subcommittee hearing examined the Obama Administration’s approval of Medicaid demonstration projects. The Energy and Commerce Health Subcommittee also reviewed three bipartisan bills that aim to improve health care for newborns, infants, and children. Specifically, members discussed:
- HR 2820, the Stem Cell Therapeutic and Research Reauthorization Act, to reauthorize programs that promote bone marrow, adult stem cell, and cord blood donations, match donors and recipients, and link patients to care.
- HR 1462, the Protecting Our Infants Act of 2015, to address the rise of prenatal opioid abuse and neonatal abstinence syndrome.
- HR 1344, the Early Hearing Detection and Intervention Act of 2015, to reauthorize a program for early detection, diagnosis and treatment regarding deaf and hard-of-hearing newborns, infants, and young children.